Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Update on upper tract urothelial carcinoma

Sima Porten • 13 Feb 2020
GU Cancers 2020
Genitourinary Cancer

Sima Porten, MD, MPH, FACS, University of California, San Francisco, CA, discusses some of the progress made for upper tract urothelial carcinoma (UTUC), with specific reference to the POUT trial (NCT01993979). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Sima Porten

Current obstacles in the treatment of urothelial carcinoma
4:31
Current obstacles in the treatment of urothelial carcinoma
Sima Porten • 13 Feb 2020
Bladder cancer: combining IDO inhibitors with immunotherapy
0:56
Bladder cancer: combining IDO inhibitors with immunotherapy
Sima Porten • 13 Feb 2020
Blue light cystoscopy for bladder cancer
0:40
Blue light cystoscopy for bladder cancer
Sima Porten • 13 Feb 2020

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals